|
Regenerative Medicine
|
US$
100 |
|
Feb-2024 |
Doc　#39781 |
|
| Printed Page Length :
16
pages |
| Number of Tables :
2 |
| Number of Figures:
1 |
|
Market Overview
|
|
Despite the current challenges facing the launch of local cell therapy products in Taiwan and the intense competition faced by surgical suture materials from Chinese players in overseas markets, the domestic market for high-end tissue engineering biomedical material application products remains promising. This is largely due to concerted efforts by domestic players to consolidate and expand markets in China, ASEAN, and emerging markets such as the Middle East and Eastern Europe.
|
|
|
|